Article: Form 424B5 Antelope Enterprise Holdings Ltd

Article - Media, Publications

Form 424B5 Antelope Enterprise Holdings Ltd

Toppan Merrill, 12 February 2021

We are offering 588,236 common shares at a price of $3.57 per share (the “Shares”) to selected institutional investors pursuant to this prospectus supplement and the accompanying prospectus and a securities purchase agreement with such investors. In a concurrent private placement, we are selling to such investors warrants to purchase 588,236 common shares (the “Warrants”). The Warrants and the common shares issuable upon the exercise of the Warrants are being offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder, and they are not being offered pursuant to this prospectus supplement and the accompanying prospectus.

As of February 11, 2021, the aggregate market value of our outstanding common shares held by non-affiliates was approximately $8.69 million, based on 3,108,020 outstanding common shares, of which outstanding shares 2,269,037 were held by non-affiliates, and a per share price of $3.83 based on the closing price of our common shares on February 11, 2021.

Read Full Article

Article: Tucows Announces $40 Million Stock Buyback Program

Article - Media, Publications

Tucows Announces $40 Million Stock Buyback Program

GLOBE NEWSWIRE, 10 February 2021

Tucows Inc. (NASDAQ: TCX, TSX: TC) announced today that its Board of Directors has approved a stock buyback program to repurchase, from time to time, up to $40 million of its common stock in the open market.

The new $40 million buyback program will commence February 10, 2021 and will terminate on or before February 9, 2022. Purchases for the new buyback program will be made exclusively through the facilities of the Nasdaq Capital Market. The previously announced $40 million buyback program for the period February 13, 2020 to February 12, 2021 has been terminated. Continue reading “Article: Tucows Announces $40 Million Stock Buyback Program”

Article: Mercurity Fintech Holding Inc. Announces Results of 2021 Extraordinary General Meeting

Article - Media, Publications

Mercurity Fintech Holding Inc. Announces Results of 2021 Extraordinary General Meeting

PRNewswire, 09 February 2021

Mercurity Fintech Holding Inc. (the “Company”) (Nasdaq: MFH) today announced the results of its 2021 Extraordinary General Meeting, held on February 5, 2021 in Beijing, where it adopted resolutions, effective immediately, to: (i) increase the authorized share capital of the Company from US$50,000 to US$250,000; and (ii) re-elect following nominees as members of the Company’s Board of Directors: Continue reading “Article: Mercurity Fintech Holding Inc. Announces Results of 2021 Extraordinary General Meeting”

Article: Form 8-K Vinco Ventures, Inc.

Article - Media, Publications

Form 8-K Vinco Ventures, Inc.

M2 Compliance, 21 January 2021

On January 19, 2021, Vinco Ventures, Inc. (“Vinco Ventures”), ZVV Media Partners, LLC (the “Company”) and Zash Global Media and Entertainment Corporation (“ZASH”) entered into a Contribution Agreement (the “Agreement”). Vinco Ventures and ZASH desire to establish the newly formed Company in order to engage in the development and production of consumer facing content and related activities.

Under the terms of the Agreement, Vinco Ventures and ZASH shall contribute certain assets (the “Contributed Assets”) to the Company. At Closing, Vinco Ventures and ZASH shall enter into a limited liability operating agreement of the Company and a content distribution agreement with American Syndication Media Corporation (“ASMC”). The Company shall not assume any liabilities of either Vinco Ventures or ZASH except those liabilities arising in or specifically relating to periods, events or occurrences happening with respect to the Contributed Assets on or after the Closing Date. In consideration of the Contributed Assets, the Company shall issue to Vinco Ventures and ZASH 5,000 Units. The transaction closed on January 19, 2021.

Read Full Article

Article: InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe

Article - Media, Publications

InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe

PRNewswire, 19 January 2021

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), today announced that executives of the Company will speak at the 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe (“CDP Europe”). CDP Europe will be held virtually from January 19-21, 2021. Michael Woudenberg – Vice President, Chemistry, Manufacturing & Controls, Karen Long – Senior Director, Drug Development, and Prof. Mauro Maccarrone PhD – Scientific Advisor to InMed will all be featured as expert speakers at the event.

Read Full Article

Article: Are InMode Ltd. (NASDAQ:INMD) Investors Paying Above The Intrinsic Value?

Article - Media, Publications

Are InMode Ltd. (NASDAQ:INMD) Investors Paying Above The Intrinsic Value?

Simply Wall St, 18 January 2021

How far off is InMode Ltd. (NASDAQ:INMD) from its intrinsic value? Using the most recent financial data, we’ll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to today’s value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Don’t get put off by the jargon, the math behind it is actually quite straightforward.

Remember though, that there are many ways to estimate a company’s value, and a DCF is just one method. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

Read Full Article

Article: Form 424B5 Bionano Genomics, Inc

Article - Media, Publications

Form 424B5 Bionano Genomics, Inc

EDGARFILINGS LTD, 07 January 2021

Common Stock We are offering shares of our common stock at a purchase price of $ per share pursuant to this prospectus supplement. Our common stock is listed on the Nasdaq Capital Market under the symbol “BNGO.” On January 6, 2021, the last reported sale price of our common stock was $4.77 per share. We are an “emerging growth company” as defined under the federal securities laws and, as such, have elected to comply with certain reduced reporting requirements for this prospectus supplement and may elect to do so in future filings. Our business and an investment in our securities involve significant risks. These risks are described under the caption “Risk Factors” beginning on page S-5 of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement and the accompanying prospectus.

Read Full Article

Article: Exuberance Over Good News Drives Bionano Genomics’ Wild Week

Article - Media, Publications

Exuberance Over Good News Drives Bionano Genomics’ Wild Week

John Alford, 04 January 2021

Bionano Genomics, Inc. (BNGO) has been on a wild, meteoric rise in the past few days, and after hours on the 31st it continued to skyrocket, rising to $4 a share. On the 31st of December alone, counting market and after-hours trading, share prices surged $1.90, almost doubling. This capped a wild week, and is a momentum-driven mania trade not based on the previous performance or long-term trend of the company. While recently reporting one good report (via a paid PR service), there are obvious issues surrounding the company to the investor that takes the time to evaluate their most recent 10-Q, recent and potential massive dilution, and decreasing revenue. Continue reading “Article: Exuberance Over Good News Drives Bionano Genomics’ Wild Week”

Article: Is First Trust Multi Cap Growth AlphaDEX ETF (FAD) a Strong ETF Right Now?

Article - Media, Publications

Is First Trust Multi Cap Growth AlphaDEX ETF (FAD) a Strong ETF Right Now?

Zacks Equity Research, 14 December 2020

The First Trust Multi Cap Growth AlphaDEX ETF (FAD) made its debut on 05/08/2007, and is a smart beta exchange traded fund that provides broad exposure to the Style Box – All Cap Growth category of the market.

What Are Smart Beta ETFs?

The ETF industry has traditionally been dominated by products based on market capitalization weighted indexes that are designed to represent the market or a particular segment of the market.

Read Full Article

Article: Vinco Ventures, Inc. Updates on Subsidiary Honey Badger Media, LLC and their Acclaimed Celebrity Influencers.

Article - Media, Publications

Vinco Ventures, Inc. Updates on Subsidiary Honey Badger Media, LLC and their Acclaimed Celebrity Influencers.

GLOBE NEWSWIRE, 10 December 2020

Vinco Ventures, Inc. (NASDAQ: BBIG), today updates on the first 30 days of their subsidiary Honey Badger Media, LLC and the advancement of its esteemed influencer list.

Honey Badger Media is a digital commerce company and one of Vinco’s key tools in the Be B.I.G. business model. The Company designs digital campaigns from scratch to monetization and leverages a 300 million plus follower network to grow advertiser-based revenue as well as Vinco’s brands and holdings. Additionally, within the first month, Honey Badger was able to sign an impressive catalog of celebrity influencers, including skateboarder and TV personality Bam Margera, Reality Television and Motivational Speaker Adalia Rose, and respected mom blogger Joy of Mom.

Read Full Article

Article: BBIG -Vinco Ventures, Inc. Updates On Subsidiary Honey Badger Media, LLC And Their Acclaimed Celebrity Influencers.

Article - Media, Publications

BBIG -Vinco Ventures, Inc. Updates On Subsidiary Honey Badger Media, LLC And Their Acclaimed Celebrity Influencers.

NASDQplayer97, 10 December 2010

Vinco Ventures, Inc. (NASDAQ:BBIG), today updates on the first 30 days of their subsidiary Honey Badger Media, LLC and the advancement of its esteemed influencer list.

Honey Badger Media is a digital commerce company and one of Vinco’s key tools in the Be B.I.G. business model. The Company designs digital campaigns from scratch to monetization and leverages a 300 million plus follower network to grow advertiser-based revenue as well as Vinco’s brands and holdings. Additionally, within the first month, Honey Badger was able to sign an impressive catalog of celebrity influencers, including skateboarder and TV personality Bam Margera, Reality Television and Motivational Speaker Adalia Rose, and respected mom blogger Joy of Mom.

Read Full Article

Article: Why Nano-X Imaging Stock Continues to Surge

Article - Media, Publications

Why Nano-X Imaging Stock Continues to Surge

Rich Smith, 02 December 2020

Shares of Nano-X Imaging (NASDAQ: NNOX), the Israeli X-ray machine maker with the novel business idea of giving its products away for free (and then taking a cut of the revenue when doctors use the machines to take X-rays), is back in investors’ favor again. Over the past 10 days, shares of Nano-X have surged 79% — including a big 7% jump today as of 2:20 p.m. EST.

Why is Nano-X doing so well today? To learn the answer, you first have to go back in time a couple of months to mid-September, when Citron Research published a report branding Nano-X as “Theranos 2.0” and a company that not only “has never published any data showing their machine’s images compared to images from a standard CT scanner,” but has actually never even showed investors that it has a machine at all.

These and similar accusations from the short-seller devastated Nano-X’s stock over the summer, but on Thursday starting at 11:30 a.m. EST, Nano-X will attempt to refute all of the above by hosting “a live demonstration that will showcase the Nanox digital x-ray source tube and a range of 2D and 3D imaging applications performed by the Nanox.ARC at the 2020 Radiology Society of North America Virtual Annual Meeting.”

Read Full Article

Article: Jupiter Wellness Awarded Exclusive Distribution Agreement with Safe Sea(R) for the Entire Florida Market

Article - Media, Publications

Jupiter Wellness Awarded Exclusive Distribution Agreement with Safe Sea(R) for the Entire Florida Market

ACCESSWIRE, 09 November 2020

upiter Wellness, Inc. (NASDAQ:JUPW), a cutting-edge wellness brand dedicated to providing multiple therapeutic and medical uses of cannabidiol (CBD), today announced the signing of an exclusive distribution agreement for Safe Sea products. The distribution agreement’s initial phase is through the end of 2021 and covers all of Florida.

Safe Sea develops, markets, and distributes the world’s first sunscreen that provides protection from jellyfish stings and sea lice. The Safe Sea line of products are also patent protected, biodegradable and safe to marine life, and provide UVA/UVB protection from the sun’s harmful rays. Continue reading “Article: Jupiter Wellness Awarded Exclusive Distribution Agreement with Safe Sea(R) for the Entire Florida Market”

Article: Jupiter Wellness, Inc. Announces Closing of Initial Public Offering

Article - Media, Publications

Jupiter Wellness, Inc. Announces Closing of Initial Public Offering

ACCESSWIRE , 04 November 2020

Jupiter Wellness, Inc. (NASDAQ:JUPW) (the “Company”), a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (CBD) via a multitude of convenient products, today announced the closing of its initial public offering of 933,333 units consisting of one share of common stock and one warrant for gross proceeds of $7,000,000, before deducting offering expenses. Aegis Capital has fully exercised its option to purchase up to 140,000 warrants. The shares and warrants began trading on The Nasdaq Capital Market on October 30, 2020, under the symbols “JUPW” and “JUPWW.” Continue reading “Article: Jupiter Wellness, Inc. Announces Closing of Initial Public Offering”

Article: 180 Life Sciences Corp. (ATNF) FORM 424B4

Article - Media, Publications

180 Life Sciences Corp. (ATNF) FORM 424B4

Seeking Alpha, 02 November2021

This prospectus relates to the proposed resale or other disposition from time to time of an aggregate of 9,108,836 shares of the common stock, par value $0.0001 per share, of KBL Merger Corp. IV, a Delaware corporation, by the selling stockholders identified in this prospectus, of which: (i) 750,000 shares of common stock are held by certain of the selling stockholders identified in this prospectus that are party to either the June SPA or the September SPA; (ii) 1,388,890 shares of common stock are issuable to one of the selling stockholders identified in this prospectus that is a party to the June SPA upon the conversion of $3,666,666.66 of our Series A Convertible Preferred Stock (“Series A Stock”) and all accrued and unpaid dividends on such Series A Stock based on a conversion price (after giving effect to certain potential anti-dilution adjustments) of $2.64 per share; (iii) 2,592,195 shares of common stock are issuable to certain of the selling stockholders identified in this prospectus that are party to either the June SPA or the September SPA upon the conversion of $4,713,077.39 aggregate principal amount of our secured convertible 10% original issue discount promissory notes (the “Investor Notes”), plus accrued and unpaid interest thereon, based upon a floor conversion price of $2.00 per share; (iv) 198,751 shares of common stock are issuable to our Sponsor upon the conversion of an unsecured convertible promissory note in the aggregate principal amount of $795,003 (the “Convertible Sponsor Note”); (v) 1,968,750 shares of common stock are founder shares that are held by our Sponsor;

Read Full Article

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?